Tasca Therapeutics Corp. announced its $52 million Series A funding that will allow it to bring its first cancer drug into ...

Women should have the option of taking their own test samples for cervical cancer screening, an influential health panel said ...

Qure's AMT-130 shows promising results for Huntington’s disease. Learn why QURE stock faces commercialization challenges ...